12 Nov 2025
11 months ago
1148 views
The Medicines Amendment Bill in New Zealand has lifted the prohibition on advertising medicines at medical conferences and trade shows, signaling the country's readiness for business, according to Regulation Minister David Seymour and Health Minister Simeon Brown. This change is expected to inject cash into local economies through the Red Tape Tipline and provide Kiwis with increased access to needed medicines. The move is projected to generate $90 million in revenue over the next few years, attracting major medical conferences to New Zealand and fostering economic activity.
12 Nov 2025
11 months ago
1145 views
Associate Health Minister David Seymour welcomes the passing of the Medicines Amendment Bill, which introduces the 'Rule of Two' for faster approval of medicines with recognition from two overseas jurisdictions. The streamlined verification pathway aims to increase access to medicines for New Zealanders, starting with countries like Australia, the United States, and the United Kingdom. The government prioritizes improving patient outcomes by enhancing access to medicines through initiatives like increased Pharmac funding, patient input in funding decisions, and efficient regulatory processes.
14 Oct 2025
1 year ago
1291 views
Cabinet papers reveal upcoming Medical Products Bill changes including the removal of pharmacy ownership restrictions to enhance access to healthcare. The bill will introduce a supervisory pharmacist role and allow advertising of unapproved medicines under certain conditions. Modernizing advertising regulations will provide better access to medical product information while ensuring consumer safety.
24 Sep 2025
1 year ago
1212 views
Associate Health Minister David Seymour and Health Minister Simeon Brown are pleased with Pharmac's negotiations to increase access to medicines, recognizing the significant impact on New Zealanders' health and well-being. Pharmac's proposal includes funding for five new treatments for various conditions, potentially benefiting over 1,700 people in the first year and up to 4,000 by year five. The proposal aims to improve patient care by introducing quicker administration methods, saving hospital infusion hours and freeing up resources for other treatments, while also emphasizing the importance of public consultation in decision-making processes.
19 Aug 2025
1 year ago
1650 views
Associate Health Minister David Seymour highlights that Medsafe has been improving its efficiency in approving new medicines, with significant reductions in evaluation timeframes for both innovative and generic medicines. The implementation of initiatives like the Rule of Two and leveraging AI technology are expected to further expedite the approval processes. The focus is on ensuring faster access to vital medications for New Zealanders, with a commitment to a regulatory system that prioritizes timely approval without compromising safety.
31 Jul 2025
1 year ago
2953 views
Associate Education Minister David Seymour supports Pharmac's decision to lower the cost of certain funded medicines in order to allocate more funding for new medicines, emphasizing the critical impact of pharmaceutical funding on the lives of New Zealanders. The annual tender process allows Pharmac to save between $30 million and $50 million annually by reducing costs of existing medicines to fund new ones. Pharmac has implemented additional consultation steps in the tender process to gather feedback from patients, healthcare professionals, and advocacy groups, aiming for a more patient-centric approach in decision-making.
22 Jul 2025
1 year ago
2524 views
Associate Education Minister David Seymour welcomes Pharmac's new consumer working group to improve its collaboration with health consumers, emphasizing the importance of patient input in decision-making processes. The working group, led by Dr. Malcolm Mulholland, includes members representing various health conditions, aiming to reset the relationship between Pharmac and the consumer community. The government's support includes increased funding for Pharmac to negotiate better deals for medicine and enhance access for patients and their families.